The 20 Best 2q37 Deletion Syndrome Doctors Near Me in Brighton, MI

In 2008, Dr. Dlugosz was named Poth Professor of Cutaneous Oncology in the Dermatology Department at the University of Michigan in Ann Arbor. He is Scientific Director of the Cutaneous Oncology Program of the University of Michigan Comprehensive Cancer Center. He received his M.D. at the Pennsylvania State University College of Medicine in 1984, did an internship at the Roger Williams General Hospital in Providence, RI, and completed his dermatology residency, including a year as Chief Resident, at the University of Pennsylvania in Philadelphia, in 1988. He received his post-doctoral training with Dr. Stuart Yuspa at the National Cancer Institute, where he subsequently established an independent research program prior to his recruitment to the University of Michigan in 1997.Dr. Dlugosz has received multiple awards, grants, and fellowships from the National Institutes of Health, American Cancer Society, American Association for Cancer Research, Society for Investigative Dermatology, and Dermatology Foundation. He was elected to the American Society for Clinical Investigation in 2002, has been included in the Best Doctors in America listing since 2003, and was elected to the American Dermatological Association in 2005.The National Institutes of Health and other scientific agencies frequently enlist Dr. Dlugosz as a grant reviewer. He is also an ad hoc reviewer for multiple scholarly journals, and is frequently invited to speak, or chair sessions, at major scientific meetings both in the United States and abroad. Dr. Dlugosz is an author on over 60 published papers.Dr. Dlugosz's basic research program is centered on two interrelated areas. He is investigating how the abnormal regulation of an embryonic signaling pathway, called the Hedgehog pathway, causes tumor development in skin and several other organs. In other studies, he is investigating the role of the Hedgehog pathway in development, growth, and regeneration of hair follicles and related structures. Dr. Dlugosz is rated as an Advanced provider by MediFind in the treatment of 2q37 Deletion Syndrome. He is also highly rated in 88 other conditions, according to our data. His clinical expertise encompasses Cicatricial Pemphigoid, Pemphigus, Bullous Pemphigoid, and Pemphigus Vulgaris. Dr. Dlugosz is board certified in Dermatology.

Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and also facilitates regular exams and surveillance for patients at risk for endocrine tumors. Dr. Else is rated as an Advanced provider by MediFind in the treatment of 2q37 Deletion Syndrome. He is also highly rated in 105 other conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Adrenal Gland Adenoma, Neuroendocrine Tumor, and Thyroidectomy. Dr. Else is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Linda Rossetti is a Pediatrics specialist and a Medical Genetics provider practicing medicine in Grand Rapids, Michigan. She has been practicing medicine for over 10 years. Dr. Rossetti is rated as an Advanced provider by MediFind in the treatment of 2q37 Deletion Syndrome. She is also highly rated in 87 other conditions, according to our data. Her clinical expertise encompasses Smith-Magenis Syndrome, Miller-Dieker Syndrome, Chromosome 6q Duplication, and Chromosome 8p Deletion. Dr. Rossetti is board certified in American Board Of Medical Genetics And Genomics and American Board Of Pediatrics.

Daniel Fain is a Pediatric Neurologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 34 years. Dr. Fain is rated as an Advanced provider by MediFind in the treatment of 2q37 Deletion Syndrome. He is also highly rated in 84 other conditions, according to our data. His clinical expertise encompasses Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Legius Syndrome, and Seizures. Dr. Fain is board certified in American Board Of Psychiatry And Neurology, Epilepsy - 2016 and American Board Of Psychiatry And Neurology, Neurology With Special Qualification In Child Neurology - 1999. Dr. Fain is currently accepting new patients.

Rawad Obeid is a Pediatric Neurologist practicing medicine in Royal Oak, Michigan. He has been practicing medicine for over 20 years. Dr. Obeid is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Intraventricular Hemorrhage of the Newborn, GAPO Syndrome, Delayed Growth, and Genetic Epilepsy with Febrile Seizures Plus (GEFS+). Dr. Obeid is board certified in American Board Of Psychiatry And Neurology and American Board Of Pediatrics. Dr. Obeid is currently accepting new patients.

Jessica Priestley is a Pediatrics specialist and a Medical Genetics provider practicing medicine in Grand Rapids, Michigan. She has been practicing medicine for over 8 years. Dr. Priestley is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Fabry Disease, Biotinidase Deficiency, Ornithine Transcarbamylase Deficiency, and Multiple Sulfatase Deficiency. Dr. Priestley is board certified in American Board Of Medical Genetics And Genomics, American Board Of Medical Genetics And Genomics, and American Board Of Pediatrics.

Stephanie Campbell is a Pediatrics provider practicing medicine in Royal Oak, Michigan. She has been practicing medicine for over 10 years. Dr. Campbell is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Increased Head Circumference, Delayed Growth, Congenital Athymia, and Acromesomelic Dysplasia Campailla Martinelli Type. Dr. Campbell is board certified in American Board Of Pediatrics. Dr. Campbell is currently accepting new patients.

Steven Deroos is a Pediatric Neurologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 32 years. Dr. Deroos is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Cerebral Palsy, Spastic Diplegia Infantile Type, Moebius Syndrome, and Dandy-Walker Syndrome. Dr. Deroos is board certified in American Board Of Psychiatry And Neurology, Neurology With Special Qualification In Child Neurology - 2005. Dr. Deroos is currently accepting new patients.

Dr. Yolanda Helfrich is a clinical professor of dermatology and the residency program director of the Department of Dermatology at the University of Michigan Medical School.Dr. Helfrich’s primary clinical focus is on medical dermatology. She has a special interest in rosacea, and has been invited to speak and write nationally about the pathogenesis and treatment of rosacea. She serves on the National Rosacea Society Medical Advisory Board. She also has a clinical specialization in the follow-up and diagnosis of high-risk skin cancer patients and runs a specialty clinic devoted to the care of patients with alopecia (hair loss).Throughout her career, Dr. Helfrich has had a strong interest in clinical research, and served as the Director of the Program for Clinical Research in Dermatology (PCRiD) in the department for 12 years. She has served as Primary Investigator on over 25 departmental and industry-sponsored clinical trials and research investigations of rosacea, atopic dermatitis, psoriasis, lichen planus, and other dermatologic conditions. She served on the Michigan Medicine Research Board of Directors Clinical Trials Subcommittee, with the key task of helping the institution create a unified clinical research enterprise, and subsequently served as one of the inaugural Medical Directors of the Neurosciences and Sensory Clinical Trials Support Unit. Dr. Helfrich embraces her role as an educator, and has served as the Residency Program Director in Dermatology since January 2016. She has worked hard to optimize the clinical training and educational environment for residents within the program. She was recently elected to the American Professors of Dermatology Program Directors Steering Committee. She also serves on the Michigan Medicine Graduate Medical Education Committee (GMEC). In 2015, she was elected to Michigan Medicine’s League of Educational Excellence, which honors instructional faculty for their extraordinary contributions to teaching and inspiring the next generation of Michigan physicians and scientists.Dr. Helfrich is a Michigan native. She grew up in Grayling and attended Grayling High School. She graduated with a B.A. in Latin and Ancient History from Swarthmore College in Pennsylvania. She subsequently attended medical school at the University of Michigan Medical School, graduating in 2001. Dr. Helfrich completed her internship in internal medicine and her residency in dermatology at the University of Michigan. She joined the faculty at the University of Michigan Department of Dermatology in 2. Dr. Helfrich is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. She is also highly rated in 52 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Rosacea, Graham-Little-Piccardi-Lassueur Syndrome, and Melanoma. Dr. Helfrich is board certified in Dermatology.

Jena Krueger is a Pediatric Neurologist practicing medicine in Grand Rapids, Michigan. She has been practicing medicine for over 16 years. Dr. Krueger is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Spinal Muscular Atrophy (SMA), Primary Lateral Sclerosis, Spinal Muscular Atrophy Type 1, and Spinal Muscular Atrophy Type 2. Dr. Krueger is board certified in American Board Of Psychiatry And Neurology, Epilepsy - 2017 and American Board Of Psychiatry And Neurology, Neurology With Special Qualification In Child Neurology - 2015. Dr. Krueger is currently accepting new patients.

Daniel Arndt is a Neurologist and a Pediatric Neurologist practicing medicine in West Bloomfield, Michigan. He has been practicing medicine for over 23 years. Dr. Arndt is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Seizures, Generalized Tonic-Clonic Seizure, Absence Seizure, and Memory Loss. Dr. Arndt is board certified in American Board Of Psychiatry And Neurology and American Board Of Psychiatry And Neurology. Dr. Arndt is currently accepting new patients.

Eric Armour is a Pediatrics specialist and a Neurologist practicing medicine in Brighton, Michigan. Dr. Armour is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Seizures, Generalized Tonic-Clonic Seizure, Tuberous Sclerosis, and Tuberous Sclerosis Complex. Dr. Armour is board certified in Clinical Neurophysiology, Neurology W/Spec Qual Child Neuro, and Epilepsy.

Jason Umfleet is a Pediatric Neurologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 26 years. Dr. Umfleet is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Absence Seizure, Partial Seizure, Epilepsy Juvenile Absence, and Seizures. Dr. Umfleet is board certified in American Board Of Psychiatry And Neurology, Epilepsy - 2017 and American Board Of Psychiatry And Neurology, Neurology With Special Qualification In Child Neurology - 2007. Dr. Umfleet is currently accepting new patients.

Elizabeth Leleszi is a Pediatrics specialist and a Pediatric Neurologist practicing medicine in Royal Oak, Michigan. She has been practicing medicine for over 24 years. Dr. Leleszi is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Migraine with Brainstem Aura, Migraine, Stereotypic Movement Disorder, and Spasmus Nutans. Dr. Leleszi is board certified in American Board Of Psychiatry And Neurology. Dr. Leleszi is currently accepting new patients.

Daniel Dapprich is a Dermatologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 24 years. Dr. Dapprich is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. He is also highly rated in 79 other conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Neurocutaneous Melanosis, Actinic Keratosis, and Giant Congenital Melanocytic Nevus. Dr. Dapprich is board certified in American Board Of Dermatology and American Board Of Dermatology.

Dr. Tejasvi received his medical degree from Karnataka Institute of Medical Sciences, India. He completed residency-training program and worked as senior resident in Dermatology and Venereology, from All India Institute of Medical Sciences, New Delhi, India. He completed post-doctoral training in genetics of psoriasis under the direction of Drs. R.P.Nair and James T. Elder at the University of Michigan, Department of Dermatology in Ann Arbor.Dr. Tejasvi's primary research interest is translational genetics, epigenetics in psoriasis and pharmacogenetics that involves application of genetic information to predict response to therapies. Dr. Tejasvi is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

Kara Hoisington is an Endocrinologist practicing medicine in East Lansing, Michigan. Dr. Hoisington is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Hypothyroidism, Obesity in Children, and Thyroid Nodule.

Dr. Sara Fossum is Clinical Assistant Professor of Dermatology and a board-certified dermatologist in the Michigan Medicine Department of Dermatology. She provides medical dermatology diagnosis and treatment to patients of all ages in our medical dermatology outpatient clinics. She has special interests in complex medical dermatology including the care of patients with bullous skin disease and hidradenitis suppurativa. Dr. Fossum is a graduate of the Medical Scientist Training Program at Northwestern University Feinberg School of Medicine where she received her medical degree and PhD degree in life sciences. Following graduation, she completed her preliminary year internship in internal medicine at Northshore University Health System in Evanston, Illinois, and her dermatology residency at the University of Michigan Department of Dermatology, where she served as co-chief resident in her final year. Dr. Fossum joined the U-M Dermatology faculty in January 2023. Dr. Fossum is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Hidradenitis Suppurativa, Melanoma, Bullous Pemphigoid, and Pyoderma Gangrenosum.

Dr. Severine Cao, Clinical Assistant Professor of Dermatology, provides medical dermatology patient care to patients of all ages at Michigan Medicine. Dr. Cao leads the U-M Skin of Color Clinic at the U-M Ypsilanti Health Center, where she specializes in the diagnosis and management of dermatologic disorders affecting patients with melanated skin Dr. Cao also provides dermatology consultation within the Michigan Medicine hospitals and emergency department.Dr. Cao is a graduate of Harvard Medical School. She completed her preliminary year internship in Internal Medicine at Brigham and Women's Hospital in Boston, MA, and her dermatology residency at the University of Michigan Department of Dermatology, where she served as co-chief resident in her final year. Dr. Cao joined the U-M Dermatology faculty in September 2022. Dr. Cao is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Hidradenitis Suppurativa, Melanoma, Kaposiform Hemangioendothelioma, and Fetal Cystic Hygroma. Dr. Cao is board certified in Dermatology.

Amro Stino, MD is an Associate Professor in the Department of Neurology in the University of Michigan Medical School, Division of Neuromuscular Medicine. Dr. Stino has expertise in the treatment of neuromuscular disorders, with special clinical and research interest in the care of patients with acquired peripheral neuropathy.A native of Ann Arbor, MI and a product of Ann Arbor schools, Dr. Stino went on to pursue a Bachelor of Science degree in Brain, Behavioral, and Cognitive Sciences from the University of Michigan, Ann Arbor, which he completed in 2006. He received his medical degree from Wayne State University, School of Medicine in Detroit, MI in 2010 and completed a transitional year internship at St. Joseph Mercy Hospital, in Ann Arbor, MI. He then completed his neurology residency training at the Wayne State University, School of Medicine – Detroit Medical Center, followed by a fellowship in clinical neurophysiology / neuromuscular medicine at The Mayo Clinic in Arizona. He joined The Ohio State University faculty in 2015 as Director of the Peripheral Neuropathy Clinic and Autonomic Lab. During his time there, he oversaw expansion of diagnostic testing and clinical operations of both, helping provide more comprehensive neuropathy care for central and southern Ohio patients seeking multi-disciplinary acquired neuropathy care. He helped obtain CIDP and CMT center of excellence accreditation. He joined the University of Michigan faculty in 2019 as Director of the Peripheral Neuropathy clinic and Co-director of the Autonomic Lab. Currently, he serves as site principal investigator on multi-center studies in the realms of metabolic and autoimmune neuropathy. He is presently conducting an investigator initiated phase 1b trial on the novel use of Lenalidomide in anti-MAG neuropathy.Dr. Stino is an advocate for patient awareness and education in autoimmune neuropathy and serves as physician liaison for the GBS-CIDP foundation, with whom he was interviewed on Good Day Columbus as part of GBS-CIDP awareness month. He also takes great interest in helping patients tackle peripheral neuropathy care in an evidence based fashion, particularly as it pertains to pain control.Dr. Stino enjoys working alongside and mentoring neuromuscular fellows, neurology residents, and medical students who rotate with him in clinic or inpatient service. He serves on the Peripheral Nerve Society Junior Board, which helps organize an annual educational course for attendees. His online videos on autoimmune neuropathy, small fiber neuropathy, and postural tachycardia syndrome have been viewed by thousands.He remains a dedicated Wolverine, despite having worked down south. Dr. Stino is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Chronic Inflammatory Demyelinating Polyneuropathy, Peripheral Neuropathy, Chronic Polyradiculoneuritis, and Familial Dysautonomia. Dr. Stino is board certified in Neurology, Clinical Neurophysiology, and Electrodiagnostic Medicine.